Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page
- CheckyesterdayChange DetectedENGOT is added as a collaborator for the study, and the associated investigator list is updated accordingly. Publication references are updated to include the Phase III DUO-E article in J Clin Oncol and the Erratum, along with a new revision version (v3.5.4).SummaryDifference0.1%

- Check8 days agoChange DetectedCollaborator listing updated to replace The Gynecologic Oncology Group (GOG) Foundation Inc with GOG Foundation and to include the DUO-E investigators; the plain-language summary citation for the DUO-E results was updated to the newer Future Oncol. 2026 article (with DOI 10.1080/14796694.2026.2638677), replacing the previous ahead-of-print citation.SummaryDifference0.0%

- Check15 days agoChange DetectedThe site update updates the revision from v3.5.2 to v3.5.3, indicating a deployment of a newer platform release. It does not describe any changes to the study data or page content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded the JCO publication citation for the Phase III DUO-E trial with the full author list and DOI, including the Erratum. Updated the revision version from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check37 days agoChange DetectedDifference0.0%

- Check51 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.